Aigen Investment Management’s NeoGenomics NEO Stock Holding History

Aigen Investment Management’s Portfolio NEO Stock Details NEO Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q1	–	Sell	-11,910	Closed	-$140K	–	703
2025 Q4	$140K	Sell	11,910 -31,280	-72%	-$337K	0.03%	504
2025 Q3	$333K	Sell	43,190 -1,247	-3%	-$8.73K	0.05%	506
2025 Q2	$325K	Buy	+44,437	New	+$359K	0.04%	505
2024 Q3	–	Sell	-21,392	Closed	-$297K	–	916
2024 Q2	$297K	Sell	21,392 -2,537	-11%	-$36K	0.06%	474
2024 Q1	$376K	Buy	+23,929	New	+$369K	0.08%	360
2023 Q4	–	Sell	-13,232	Closed	-$163K	–	978
2023 Q3	$163K	Buy	+13,232	New	+$197K	0.03%	703
2022 Q1	–	Sell	-8,533	Closed	-$274K	–	897
2021 Q4	$274K	Buy	+8,533	New	+$334K	0.02%	831
2020 Q2	–	Sell	-3,070	Closed	-$85K	–	1137
2020 Q1	$85K	Sell	3,070 -13,894	-82%	-$416K	0.01%	894
2019 Q4	$496K	Buy	+16,964	New	+$404K	0.08%	315

Other funds holding NEO

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

FLAM

First Light Asset Management Edina, Minnesota $1.65B AUM 203.21% 1-Year Est. Return

Greenhouse Funds Baltimore, Maryland $1.96B AUM 36.47% 1-Year Est. Return

Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM

First Trust Advisors Wheaton, Illinois $170B AUM 46.21% 1-Year Est. Return

Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM

Braidwell Stamford, Connecticut $2.7B AUM 88.53% 1-Year Est. Return

State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

D.E. Shaw & Co New York $210B AUM 57.28% 1-Year Est. Return

Schroder Investment Management Group London, United Kingdom $141B AUM 34.18% 1-Year Est. Return

Aigen Investment Management's NEO Position: Q1 2026 in Review

Aigen Investment Management sold out of NeoGenomics (NEO) in Q1 2026, closing a stake of 11,910 shares — an estimated $140K sold.

Aigen Investment Management first reported a position in NEO in Q4 2019 and held it in 9 quarters. The position peaked at $496K in Q4 2019. 253 funds tracked by Wall St. Rank hold NEO as of Q1 2026.

Aigen Investment Management reported no remaining NeoGenomics position as of Q1 2026 after selling out during the quarter.
Aigen Investment Management sold 11,910 NeoGenomics shares in Q1 2026, an estimated $140K.
Aigen Investment Management first reported a position in NeoGenomics in Q4 2019 and held it in 9 quarters.
Aigen Investment Management's NeoGenomics position peaked at $496K in Q4 2019.
253 funds tracked by Wall St. Rank held NeoGenomics as of Q1 2026.

Based on Aigen Investment Management's 13F filing for Q1 2026, filed 15 May 2026.